| 2017 | A novel combination treatment targeting BCL-XL and MCL1 for KRAS/BRAF-mutated and BCL2L1-amplified colorectal cancers | 조성엽; 나득채 | Article |
| 2020 | Amplification of transglutaminase 2 enhances tumor-promoting inflammation in gastric cancers | 박상희; Charles Lee; 이지은; 나득채 | Article |
| 2023 | An integrative approach for exploring the nature of fibroepithelial neoplasms | 나득채 | Article |
| 2022 | Comprehensive Molecular Characterization of Adenocarcinoma of the Gastroesophageal Junction between Esophageal and Gastric Adenocarcinomas | 나득채 | Article |
| 2021 | CRISPR screens identify a novel combination treatment targeting BCL-XL and WNT signaling for KRAS/BRAF-mutated colorectal cancers | Charles Lee; 나득채 | Article |
| 2017 | High prevalence of TP53 mutations is associated with poor survival and an EMT signature in gliosarcoma patients | 나득채; 조성엽 | Article |
| 2021 | JAK2 regulates paclitaxel resistance in triple negative breast cancers | Charles Lee; 나득채 | Article |
| 2021 | Patient-Derived Xenograft Models in Breast Cancer Research | 나득채 | Article; Book Chapter |
| 2021 | PI3K gamma delta inhibitor plus radiation enhances the antitumour immune effect of PD-1 blockade in syngenic murine breast cancer and humanised patient-derived xenograft model | 나득채 | Article |
| 2021 | Predictive biomarkers for 5-fluorouracil and oxaliplatin-based chemotherapy in gastric cancers via profiling of patient-derived xenografts | Charles Lee; 나득채 | Article |
| 2019 | Unstable Genome and Transcriptome Dynamics during Tumor Metastasis Contribute to Therapeutic Heterogeneity in Colorectal Cancers | Charles Lee; 이지은; 나득채 | Article |
